Regulatory T cells (Tregs) are a suppressive CD4+ T-cell population that help maintain immune tolerance, but in disease they can be co-opted to dampen anti-tumor or inflammatory responses. In glioblastoma multiforme (GBM), they are recruited as part of the tumor’s immunosuppressive resistance program, and the provided key fact notes that GBM recruits Tregs to support…
Tumor mutation burden (TMB) is a genomic biomarker that quantifies the number of somatic mutations in a tumor and is used primarily to predict response to immune checkpoint inhibitors. It is reviewed as a conventional predictive biomarker, including in mismatch repair-deficient endometrial cancer where it helps assess response or resistance. TMB is also described as…
HIV-1 is the human immunodeficiency virus type 1, a viral pathogen and disease target for antiviral and gene-editing strategies. Its primary relevance here is as a target for non-nucleoside reverse transcriptase inhibitors, CRISPR/Cas-mediated proviral DNA excision, and long-lasting therapeutic antibody production. The literature highlights inhibition of wild-type and drug-resistant virus, with compounds such as a19…
Melanoma is a highly aggressive skin cancer and a major model for studying immunotherapy response, tumor immune evasion, and targeted delivery strategies. It is also used as a diagnostic and classification target in convolutional neural networks and support vector machines, and as a clinical context for the cross scale multimodal framework and the essen melanoma…
Reactive oxygen species (ROS) are highly reactive oxygen-containing molecules that act as both signaling mediators and damaging oxidants, with generation often increasing downstream of interventions such as mitochondrial genome editing and nanoplatform activation. They are central to oxidative stress biology and are implicated in mitochondrial dysfunction, macrophage inflammation, apoptosis, oocyte deterioration, and infection-associated tissue injury….
